Anti-VEGF (Vascular Endothelial Growth Factor) therapy with repeated doses of drugs such as ranibizumab and aflibcept can reduce diabetic macular edema by reducing inflammation and preventing abnormal blood vessel growth used to treat edema (DME) and proliferative diabetic retinopathy (PDR). This evidence concerns the gene VEGFA and diabetic macular edema.